Investors and lenders in healthcare are not primarily buying a growth narrative. They are testing whether the numbers hold when something goes wrong. In practice that reduces to three questions: where does the revenue actually come from, what happens to it under stress, and who is accountable when it moves.
Referral formation, not market size. A catchment of ten million people is not a pipeline. What gets underwritten is how the first patients arrive — which referrers, which contracts, which payor, and how quickly that flow becomes repeatable.
Ramp-up, not steady state. Most healthcare funding failures are timing failures rather than demand failures. Utilisation builds more slowly than models assume, reimbursement pays later than assumed, and staffing costs arrive in full on day one. The first eighteen months of cashflow deserve more scrutiny than year five.
A model, not a deck. Every material line should trace to an operational driver — utilisation, staffing ratios, consumables per procedure, reimbursement rates and payment timing. A model built that way lets you answer diligence questions in the room. A model that cannot be interrogated tends to be found out in the second meeting.
This is the discipline that project finance has applied to toll roads, airports and power plants for decades, and it transfers directly to healthcare assets. We have written about that at length in Financial Modelling for Healthcare.